Dasha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 30-10-2024
- Paid Up Capital ₹ 6.00 Cr
as on 30-10-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 31.58 Cr
as on 30-10-2024
- Revenue 3103.13%
(FY 2023)
- Profit 126.51%
(FY 2023)
- Ebitda 127.76%
(FY 2023)
- Net Worth 1.65%
(FY 2023)
- Total Assets 2.43%
(FY 2023)
About Dasha Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹31.58 Cr.
Shankar Cheepirishetti, Arunalatha Cheepirishetti, Ashrit Cheepirishetti, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290TG2020PTC140212
- Company No.
140212
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dasha Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankar Cheepirishetti  | Managing Director | 29-Apr-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashrit Cheepirishetti  | Director | 29-Apr-2020 | Current |
| Arunalatha Cheepirishetti | Director | 29-Apr-2020 | Current |
| Donald Ross | Director | 29-Apr-2020 | Current |
| Snehitha Komarraj | Director | 13-Oct-2022 | Current |
Financial Performance of Dasha Pharmaceuticals.
Dasha Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 3103.13% increase. The company also saw a substantial improvement in profitability, with a 126.51% increase in profit. The company's net worth moved up by a moderate rise of 1.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dasha Pharmaceuticals?
In 2023, Dasha Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dasha Life Sciences LlpActive 3 years 10 monthsShankar Cheepirishetti and Arunalatha Cheepirishetti are mutual person
- Dasha Science Park Private LimitedActive 2 years 3 months
Shankar Cheepirishetti, Arunalatha Cheepirishetti and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Mar 2024 | ₹31.58 Cr | Open |
How Many Employees Work at Dasha Pharmaceuticals?
Unlock and access historical data on people associated with Dasha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dasha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dasha Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
